Sunshine Biopharma (SBFM) Other Non Operating Income (2016 - 2026)
Sunshine Biopharma (SBFM) posted Other Non Operating Income of -$18.0 for Q1 2026, down 800.0% on a QoQ basis from -$2.0 in Q4 2025, and down 103.99% year-over-year from $451.0 in Q1 2025.
Sunshine Biopharma (SBFM) Other Non Operating Income (2016 - 2026) Analysis & Trends
Sunshine Biopharma's Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$18.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 103.99% year-over-year to -$18.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2173.0 (up 105.74% YoY) and the FY2025 annual result came in at $2642.0, up 105.99% from the prior year.
- Other Non Operating Income was -$18.0 for Q1 2026 at Sunshine Biopharma, down from -$2.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $286535.0 in Q2 2024 and bottomed at -$340003.0 in Q4 2024.
- A 5-year average of -$1844.5 and a median of $15.0 in 2023 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 109883.52% in 2024, while the deepest fall reached 871702.56% in 2024.
- Sunshine Biopharma's Other Non Operating Income stood at -$521.0 in 2022, then jumped by 92.51% to -$39.0 in 2023, then sank by 871702.56% to -$340003.0 in 2024, then soared by 100.0% to -$2.0 in 2025, then tumbled by 800.0% to -$18.0 in 2026.
- Business Quant data shows SBFM's Other Non Operating Income at -$18.0 in Q1 2026, -$2.0 in Q4 2025, and $253.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.00 |
| Dec 31, 2025 | -2.00 |
| Sep 30, 2025 | 253.00 |
| Jun 30, 2025 | 1,940.00 |
| Mar 31, 2025 | 451.00 |
| Dec 31, 2024 | -340,003.00 |
| Sep 30, 2024 | 15,153.00 |
| Jun 30, 2024 | 286,535.00 |
| Mar 31, 2024 | -5,767.00 |
| Dec 31, 2023 | -39.00 |
| Sep 30, 2023 | 40.00 |
| Jun 30, 2023 | -261.00 |
| Mar 31, 2023 | 15.00 |
| Dec 31, 2022 | -521.00 |
| Sep 30, 2022 | 25.00 |
| Jun 30, 2022 | 10,852.00 |
| Mar 31, 2022 | -9.00 |
| Dec 31, 2021 | 19.00 |
| Sep 30, 2021 | 7,688.00 |
| Jun 30, 2021 | 221.00 |